Cargando…
A pilot clinical phase II trial MemSID: Acute and durable changes of red blood cells of sickle cell disease patients on memantine treatment
An increase in abundance and activity of N‐methyl D‐aspartate receptors (NMDAR) was previously reported for red blood cells (RBCs) of sickle cell disease (SCD) patients. Increased Ca(2+) uptake through the receptor supported dehydration and RBC damage. In a pilot phase IIa‐b clinical trial MemSID, m...
Autores principales: | Mahkro, Asya, Hegemann, Inga, Seiler, Elena, Simionato, Greta, Claveria, Viviana, Bogdanov, Nikolay, Sasselli, Clelia, Torgerson, Paul, Kaestner, Lars, Manz, Markus G., Goede, Jeroen S., Gassmann, Max, Bogdanova, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175962/ https://www.ncbi.nlm.nih.gov/pubmed/35847705 http://dx.doi.org/10.1002/jha2.11 |
Ejemplares similares
-
MEMSID: Results From a Phase 2 Pilot Study on Memantine Treatment for Sickle Cell Disease
por: Hegemann, Inga, et al.
Publicado: (2020) -
Plasma exchange for COVID‐19 thrombo‐inflammatory disease
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020) -
Is sickle cell disease a risk factor for severe COVID‐19 outcomes in hospitalized patients? A multicenter national retrospective cohort study
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021) -
Clusters of pain trajectories among patients with sickle cell disease hospitalized for vaso‐occlusive crisis: A data‐driven approach
por: Rodday, Angie Mae, et al.
Publicado: (2020) -
Patterns of healthcare utilization among patients with sickle cell disease hospitalized with pain crises
por: Rodday, Angie Mae, et al.
Publicado: (2020)